Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pretty solid sign that Constellation Brands is going all in here. See the growth opportunity and strategy in a major way. Will not be surprised to see a complete take over at some point with US legalization.
Impressive
Blah blah blah.
2.0 will be a success driving revenue. US will allow approvals for legalization. Lows are in. Question is how long will it stay in this pocket.
Loaded a few here as well. Happy that I did.
Adding
Wowzers
Looking positive moving forward!
Looking good to me with recent reports of the uptrend. I am seeing quite a few new stores opening across the west. Some of the are a decent size to as oppose to the smaller shops I initially saw.
Great example is the new store being built now on Jasper ave - downtown Edmonton.
NICE. Larger percentage of the cash flow.
Agreed. We were oversold.
Long term. RRSP.
260 shares.
Added this morning.
I’m with u. ADDED
Added as well.
Thanks Alan
Yes. Solid recovery from yesterdays oversold...
Added
Good morning.
Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada
Source: PR Newswire (Canada)
Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed
MIRABEL, QC, May 28, 2019 /CNW/ - Les Serres Vert Cannabis Inc. ("Vert Mirabel"), a subsidiary of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth") and a portfolio company of Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) ("Canopy Rivers") has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for cannabis production. Vert Mirabel was established in December 2017 between Canopy Growth, Canopy Rivers, and Les Serres Stéphane Bertrand ("Bertrand").
"We are thrilled that the operational infrastructure at Vert Mirabel is now fully online with over 500,000 sq. ft. already in production," said Olivier Dufourmantelle, Chief Operating Officer, Canopy Rivers. "Vert Mirabel is a key asset for Canopy Rivers as it provides exposure to a commercially scaled source of locally grown, premium quality cannabis for distribution into Québec and across the country."
The licence for Vert Mirabel increases the facility's growing space by 190,000 sq. ft. It brings Canopy Growth's total Canadian licensed production footprint to approximately 4.6 million sq. ft, another step towards its nearly 5.6 million sq. ft. national platform. The Vert Mirabel facility leverages Bertrand's multi-generational greenhouse operational expertise to produce high-quality cannabis.
"The final licence for Vert Mirabel strengthens our operations and will allow us to increase supply to meet the recreational market demand," said Mark Zekulin, President and co-CEO, Canopy Growth. "From everyone at Canopy Growth, we congratulate the Bertrand family and their team for achieving a fully licensed, large-scale cannabis operation in under 18 months."
Bertrand is a large-scale greenhouse operator and, prior to converting to cannabis, it was the largest producer of pink tomatoes in Canada. "We are proud to announce that our venture with Canopy Growth and Canopy Rivers has reached this milestone," said Stéphane Bertrand. "Obtaining this licence will allow us to pursue our production goals in order to expand our footprint to meet the needs of the Québec market."
Here's to Future Growth (in Québec).
About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the Company's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.
The Company's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
The Company operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 4.6 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This news release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding the pedigree quality of infrastructure; Vert Mirabel being a provider of choice for Québec; and expectations for other economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; the ability of Vert Mirabel to obtain a licence to sell cannabis under applicable legislation in Canada; the ability to secure distribution and sales channels; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Circular, filed with Canadian securities regulators and available on the Company's profile on SEDAR at www.sedar.com.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cision View original content:http://www.prnewswire.com/news-releases/canopy-growth-subsidiary-and-canopy-rivers-portfolio-company-vert-mirabel-now-fully-licensed-by-health-canada-300857238.html
SOURCE Canopy Growth Corporation
Copyright 2019 Canada NewsWire
U.S. reviews CBD amid pressure to act quickly
https://www.bnn.ca/1.1264534.1558961070
Thanks for sharing. Watching now...IMPRESSIVE!
Canopy Growth acquires established skincare and well-being company This Works®
Source: PR Newswire (Canada)
London-based firm will be an integral part of Canopy Growth's entry into the natural wellness industry and further strengthens the Company's international presence
SMITHS FALLS, ON and LONDON, May 22, 2019 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") has finalized an all-cash transaction to acquire This Works for a purchase price of £43 million (CDN $73.8 million). Founded in 2004, This Works has cemented itself as a global leader in natural skincare and sleep solutions with a devout customer base spanning 35 countries.
London-based This Works will be an integral part of Canopy Growth’s entry into the natural wellness industry and further strengthens the Company’s international presence (CNW Group/Canopy Growth Corporation)
Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution products that have rewarded the company with a loyal following of customers purchasing their best-known products including deep sleep pillow spray, morning expert hyaluronic serum, and skin deep dry leg oil.
Through their unique approach of formulating solutions that work in harmony with the 24hr body clock, This Works has evolved its product lines beyond a traditional viewpoint to a more complete regimen that maximizes skin – and overall wellness – at every phase of the day, starting with a good night's sleep. This acquisition is a key aspect of a multi-faceted hemp and CBD strategy as Canopy Growth continues to build upon its vertically-integrated production and marketing platform, that currently includes thousands of acres of hemp production across several continents, hundreds of millions of dollars of capital investment into hemp-derived CBD production and processing, rapid expansion across the European Union and other key regions, and the introduction of new CBD-infused products and brands to the global beauty, wellness, and sleep solution space.
This Works CEO, Dr. Anna Persaud, will remain at the helm of business operations post-acquisition to continue moving the company forward. Since joining the company in 2009, Dr. Persaud has worked arduously to develop targeted skin solutions, which combine the brand's knowledge of the body clock with modern lifestyle learnings, all backed by science. This approach to product development is best evidenced by This Works' award-winning natural sleep solutions, with 4.2 million pillow sprays sold across Europe, the United Kingdom, China and the United States since the brand's first deep sleep pillow spray launched in 2011. Together, Canopy Growth and This Works will continue to support all of This Works' current operations with an accelerated focus on global expansion and product development to include a new line of skincare and sleep solution products infused with CBD.
"Since 2004, This Works has been committed to creating highly effective, natural skin solutions which are rooted in science and proven to work. We are excited about this new chapter in our company's history and the opportunity to join Canopy Growth, the world's leading diversified cannabis and hemp company," shared Dr. Anna Persaud. "As a leading wellness brand and a pioneer in sleep beauty products, we are passionate about the opportunity CBD offers beauty consumers. Canopy Growth will provide the expertise, research, scientific rigour and quality assurance that will allow This Works to drive the agenda in wellness beauty's ever-evolving market."
"We were struck by how loyal and satisfied the This Works customer base is, which is a testament to the integrity rooted in the company and how confidently they can stand behind their name," said Bruce Linton, Chairman & Co-CEO, Canopy Growth. "We believe CBD has the potential to disrupt the cosmetic and sleep solution industries and have been working for years to build and establish the right entry point into this opportunity. As soon as we met with Dr. Persaud and her team, we knew they were the right partner to embark with on this journey."
In addition to strengthening Canopy Growth's product offering, bringing This Works "under the canopy" will enhance the Company's international footprint and operations within the United Kingdom. In January 2019, the Company announced Spectrum Biomedical UK, a joint venture between Canopy Growth Corporation and Oxford-based research company Beckley Canopy Therapeutics to address the need for high-quality cannabis-based medicinal products in the UK.
Here's to Future (Cosmetics, Sleep, and overall Wellness) Growth.
About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the Company's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.
The Company's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
The Company operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.4 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include statements such as "This acquisition is a key aspect of a multi-faceted hemp and CBD strategy as Canopy Growth continues to build upon its vertically-integrated production and marketing platform, that currently includes thousands of acres of hemp production across several continents, hundreds of millions of dollars of capital investment into hemp-derived CBD production and processing, rapid expansion across the European Union and other key regions, and the introduction of new CBD-infused products and brands to the global beauty, wellness, and sleep solution space". Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including the Company's ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained in the Company's annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-acquires-established-skincare-and-well-being-company-this-works-300855013.html
SOURCE Canopy Growth Corporation
Copyright 2019 Canada NewsWire
https://finance.yahoo.com/news/apos-way-canopy-growth-based-121500536.html?.tsrc=applewf
What's on the Way From Canopy Growth Based on Its Latest U.S. Trademark Applications
We have a pretty good idea what kinds of products Canopy Growth (NYSE: CGC) plans to launch when Canada's cannabis beverages and edibles market opens later this year. Canopy founder and co-CEO Bruce Linton has specifically stated in the past that the company and its partner Constellation Brands intend to market a variety of cannabis-infused beverages such as "Tweed and tonic" and zero-calorie "sports recovery" drinks that contain cannabidiol (CBD).
But that's all intended for Canada. What kind of products might Canopy Growth launch in the U.S. now that it's establishing hemp operations in New York state? Several recent applications for U.S. trademarks filed by the company give some pretty good clues.
A trademark symbol in a circle with a padlock hooked through the circle.
A trademark symbol in a circle with a padlock hooked through the circle.
Image source: Getty Images.
A break and a burst into the hemp market
Canopy Growth has filed two applications for U.S. trademarks this month that definitely signal the company's plans to launch hemp-based products. The U.S. Patent and Trademark Office (USPTO) Trademark Electronic Search System (TESS) database includes filings from Canopy for the product names "Hemp Break" and "Hemp Burst."
Both of these names list the exact same types of goods and services to be covered under the trademark filing. And it's a very broad list.
Hemp Break and Hemp Burst could be skin, hair, bath, and body products. They could be hemp-derived health food supplements. They could include a wide range of hemp-based edible products, such as butter, flour, cereals, milk, snacks, chocolates, and beverages. The trademarks could even be used for clothing items including T-shirts, sweatshirts, caps, and more.
CBD, easy as 1-2-3
We've known for a while that Canopy Growth planned to extract CBD from hemp in the U.S. The company specifically stated as such when it first announced in January 2019 that it was going to build a large-scale facility in New York. Now we know what product names Canopy Growth might use for its hemp-derived CBD.
The USPTO's trademark database lists a couple of CBD-related applications filed recently by Canopy Growth: "CBD Simplified" and "CB-Tea." The trademark application for CBD Simplified covers every category that was listed for Hemp Break and Hemp Burst. So does the filing for CB-Tea, but it's pretty obvious what the intended product is with this one.
Canopy Growth could encounter some confusion with the CB-Tea trademark, though. CBTea is already a registered trademark approved in 2016. And New Age Beverages filed last year for the very similar CBD Tea trademark.
Clearly chill
The company also filed a couple of other trademark applications this month, seeking approval for "Clear Base Distillation" and "Chill Pill." Again, Canopy included the full range of goods and services listed on its applications for Hemp Break and Hemp Burst for both of these trademarking filings.
There aren't any other trademarks in the USPTO database for Clear Base Distillation. It's a much different story for Chill Pill, however. At least six other trademarks using the same name have already been registered with the USPTO.
Coming soon
Canopy Growth might not actually use any of these trademarks. But the filings with the USPTO give us a pretty good sense of what kinds of hemp-based products the company could launch. And those products could be coming to market soon.
Linton stated in February that he expects Canopy Growth will roll out hemp-based CBD products in multiple U.S. states by the end of 2019. He also indicated that Canopy could expand its hemp operations beyond New York into other states.
The important thing for investors to note is that Canopy Growth appears to be moving quickly to capitalize on the legalization of hemp in the U.S. Many project that U.S. hemp CBD sales could reach billions of dollars annually in the near future. Canopy Growth could be on the way to making its mark in a huge new market.
Impressive!
Go WEED!
Spreading fear. Lol
This is a win win relationship!
BRAVO
Churning nicely here! People taking their profits and releasing weak hands while long term investors continue to come in or add.
It is indeed!!
Well done. This is trending positive nicely!!!
To say the least!
Wow. Thanks for sharing!
Just profits.
Yipee
Agreed
I would say he is implementing a solid strategy!! Groundbreaking to say the least.
Higher lows occurring...all good.
Looking at a green start for the day.
New Jersey takes big step toward legalizing recreational pot
https://www.bnn.ca/1.1227633.1552402298